498 patients tested, 2,000 employees WFH
Cynthia Hundorfean is president and CEO of Allegheny Health Network, a Highmark Health health system in western Pennsylvania, and a member of the Managed Healthcare Executive editorial board. We emailed her some questions about how her health system is coping with the COVID-19 pandemic.
Has Allegheny Health Network had any COVID-19 cases? Yes. We are currently treating 2 COVID-19 inpatients.
Do your facilities have access to COVID-19 testing? We are currently utilizing commercial labs for testing and have tested 498 patients to date. Most of this testing continues to be done in the outpatient setting and at our emergency departments.
Have you canceled elective surgeries and other nonurgent sorts of care? If so, have you taken steps to reduce staffing levels in some way?
Yes, we have postponed all elective surgeries and nonessential clinical care. As a result, we have been moving staff into cross-functional roles as needed.
How many people are working from home and in what kind of jobs? AHN currently has more than 2,000 employees deployed to work from home across our finance, revenue cycle, analytics, clinical access, and administrative support teams. We continue to explore solutions to allow for additional teams to work remotely.
As a healthcare leader, what has been the hardest part of dealing COVID-19. Have there been any gratifying moments? The hardest part is constantly worrying about our physicians, nurses, and everyone else in our hospitals that will be routinely exposed to the virus. They will continue to be tested by this scenario, and I hope they know how much we honor them for the work they have been and are about to do.
Gratifying moments-the clock is meaningless now. There’s no beginning or end to our workday. It’s everyone working together with the same goal. It should be like this all of the time.
2023 Drug Trend Report - Xevant
May 16th 2024To effectively navigate the changing pharmacy landscape and maintain a robust, cost-effective pharmacy benefit, you must understand the forces behind rising drug trend. What’s driving your costs and what can you do about it? As a leader in the PBM analytics space, we offer a unique perspective on pivotal trend drivers. Here’s what our comprehensive analysis revealed: -A surge in utilization rates across specialty and non-specialty drugs, magnified by anti-obesity therapies -Financial strain imposed by anti-inflammatory biologics and the yet-to-be-fulfilled -promise of biosimilar savings -Persistent price inflation driving higher costs year over year
Read More
2024 Emerging Leaders in Healthcare — Submit For a Chance to Be Featured in MHE's August Issue
May 14th 2024MHE Editors are seeking diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests. Eligible candidates are early or mid-career leaders with less than 10 years of experience. Award winners will enjoy complimentary passes to the PBMI Annual National Meeting in Orlando, Florida, from Sept. 4-6. Additional perks include a feature in our August issue, a subscription to MHE and more!
Read More